How Metastatic Cancer Cells Hide and Multiply in Lungs

Metastatic cancer cells use a two-stage process to colonize the lungs by first entering a dormant state to avoid detection before triggering a growth phase, according to research reported by Medical Xpress on August 8, 2026. This mechanism allows cancer cells to hide from the immune system and survive initial chemotherapy before eventually multiplying into secondary tumors.

The findings describe a specific sequence where disseminated tumor cells (DTCs) arrive in the lung environment and immediately pivot to a quiescent, or non-dividing, state. This dormancy period prevents the cells from exhibiting the rapid growth markers that typically alert the immune system or make them susceptible to drugs that target actively dividing cells.

Once the cells have established a foothold and the local environment becomes favorable, they undergo a second stage. In this phase, the cells reactivate and begin rapid proliferation, leading to the formation of clinically detectable metastatic nodules.

Mechanisms of Cancer Cell Dormancy in the Lungs

The first stage of this process involves the cancer cells adapting to the lung’s microenvironment. According to the Medical Xpress report, these cells essentially “hide” by suppressing the metabolic and genetic signals associated with cell division. This state of dormancy can last for weeks, months, or even years.

This dormancy is a survival strategy. Most conventional chemotherapy treatments target cells that are in the process of dividing. By remaining quiescent, metastatic cells avoid the effects of these treatments, creating a reservoir of cancer cells that can persist long after a primary tumor has been removed or treated.

Triggers for Metastatic Reactivation

The transition from the hiding phase to the multiplication phase is driven by changes in the lung tissue. The research indicates that the cells do not wake up randomly but respond to specific signals within the lung microenvironment that signal it is safe or advantageous to grow.

When these triggers are activated, the cells shift their genetic expression back to a proliferative state. This second stage is what leads to the emergence of metastatic disease, often occurring long after the initial cancer diagnosis, which explains why some patients experience recurrence after years of remission.

Clinical Implications for Cancer Treatment

Understanding this two-stage process suggests that treating the dormant phase is as critical as treating active tumors. Because dormant cells are resistant to standard chemotherapy, researchers are looking for ways to either keep these cells in a permanent state of sleep or force them to wake up so they can be killed by existing drugs.

The ability of cancer cells to modulate their activity based on the lung environment highlights the importance of the “seed and soil” hypothesis, where the “seed” (the cancer cell) requires a specific “soil” (the lung environment) to successfully grow. Identifying the exact signals that trigger the shift from dormancy to multiplication could lead to new therapies designed to block those specific signals.